GREAT NEWS FLASH: AP Surprises With Article Noting Adult Stem Cell Research Outpacing Embryonic
The Associated Press surprised readers with a new story on the contrasts between adult and embryonic stem cell research and a headline indicating what pro-life advocates have long known: the use of adult stem cell research is helping patients now and far outpacing embryonic studies.
"For all the emotional debate that began about a decade ago on allowing the use of embryonic stem cells, it's adult stem cells that are in human testing today. An extensive review of stem cell projects and interviews with two dozen experts reveal a wide range of potential treatments," AP admitted.
A few of the examples highlighted include multiple sclerosis, heart damage, juvenile diabetes, and blindness from chemical burns.
"Apart from these efforts, transplants of adult stem cells have become a standard lifesaving therapy for perhaps hundreds of thousands of people with leukemia, lymphoma and other blood diseases," AP noted.
Dr. David Scadden of Harvard told the news service that the ability of adult stem cells to help patients with a wide range of diseases and conditions helps it stand out from embryonic, which has never helped a single person